The Export Control Bottleneck
What happened
The Commerce Department's Bureau of Industry and Security, which administers export licenses for AI chips and dual-use technologies, has seen significant staffing losses and is now operating under tighter internal oversight. Export license approvals that previously took weeks are now taking several months. Chipmakers and their customers are sitting on hardware they have paid for but cannot legally ship. Simultaneously, two March 2026 cases revealed AI chips reaching restricted destinations through shell company networks in third countries. Congress is advancing bipartisan legislation to update the underlying export control statute, but the immediate operational bottleneck is at the agency level, not the legal level.
The US has built an export control regime ambitious enough to reshape global AI development but not staffed or managed well enough to execute it. The result is not security: it is an unpredictable delay system that drives compliant buyers toward alternative suppliers while sophisticated evaders route around it anyway.
The Hidden Bet
Export delays harm China more than US allies
The delays are not selective by country. Allied nations, neutral countries, and US companies' own overseas operations all wait in the same queue. India, Saudi Arabia, and the UAE, all actively investing in AI infrastructure, are waiting the same months-long periods as anyone else. The regime is hardening relationships with potential partners at exactly the moment the US needs to build them.
Chip smuggling represents a marginal problem that doesn't undermine the regime
The two documented cases in March were ones that got caught. Shell company routing through Singapore, Malaysia, and the UAE is a known pattern. BIS's own enforcement capacity is constrained by the same staffing losses affecting licensing. If the agency cannot process legitimate applications efficiently, it also cannot monitor illegitimate ones comprehensively.
Tighter oversight inside BIS is making the controls more effective
Bureaucratic review layers slow approvals for clear cases as much as ambiguous ones. The staffing losses and oversight expansion may be a response to political pressure rather than evidence of prior laxness. Adding review steps to an understaffed agency does not produce more scrutiny; it produces longer queues.
The Real Disagreement
The actual fork is between two theories of how chip controls work. Theory one: restricting supply of the most advanced chips slows China's AI development, and the collateral damage to allied buyers is an acceptable cost. Theory two: China is building out its own semiconductor ecosystem, and every month the US delays a legitimate sale to an allied buyer is a month that ally looks at SMIC or domestic alternatives. On theory one, the bottleneck is an operational problem to fix. On theory two, the bottleneck is a strategic mistake that is self-correcting only in the worst direction. The smuggling cases support theory two: the chips reach China anyway, but the delay structure has already accelerated the diversification away from US supply chains.
What No One Is Saying
No one in the administration will say that the BIS staffing losses are partly a deliberate management outcome. DOGE-style pressure on federal agencies has hollowed out technical licensing staff across multiple departments. The export control bureaucracy is not uniquely understaffed; it is understaffed for the same reason TSA, FDA, and DHS are operating at reduced capacity. The chip control regime is the most consequential casualty of a general government-shrinking project that did not distinguish between expendable and critical functions.
Who Pays
US chipmakers and their shareholders
Immediate; already affecting Q1 and Q2 2026 revenue recognition
Months-long delays on approved sales defer revenue and create customer relationships that competitors can exploit. Nvidia, Intel, and AMD are watching their order books grow while fulfillment stalls.
Allied-country AI companies and data centers
Ongoing; compounds each month the queue does not clear
Companies in India, UAE, Saudi Arabia, and Southeast Asia building out AI infrastructure face the same delays as Chinese buyers, but unlike Chinese buyers they are not building alternatives. The effect is a competitive disadvantage for US-aligned AI ecosystems.
BIS licensing staff
Already happening; likely to worsen through 2026
Surviving staff are processing a growing queue with fewer colleagues. Turnover creates institutional knowledge loss. Each departure makes the remaining staff's job harder, producing a cycle that accelerates attrition.
Scenarios
Operational Fix
Commerce hires or reassigns staff to BIS, creating a dedicated surge team for chip licensing. Backlog clears over 90 days. Controls remain in place but processing returns to weeks rather than months.
Signal Commerce announces a BIS staffing expansion with specific FTE numbers; average processing time reported back below 45 days by June.
Legislative Modernization
The bipartisan Senate bill passes and creates a streamlined licensing framework for allied countries, reducing the queue by exempting trusted-partner applications from full review. BIS resources concentrate on the remaining high-risk applications.
Signal The Senate bill gains 60 votes; House takes it up before the August recess.
Supply Chain Diversion
Allied-country buyers accelerate purchases from non-US chipmakers and develop domestic capacity. The US export control regime remains in place but becomes less meaningful as the global chip market diversifies away from US-controlled hardware.
Signal TSMC, Samsung, and ASML report significant order increases from customers who previously sourced exclusively from Nvidia or AMD; US market share in advanced AI accelerators drops below 60%.
What Would Change This
If the bipartisan semiconductor export control legislation passes and creates a trusted-partner fast-track, the allied-country delay problem resolves without changing the China controls. That would be the best-case outcome for the administration's stated goals. It requires Congress to move faster than it usually does on export control legislation, which it has not historically done.